| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | 0.003 | 1 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.0024 | 1 |